Building Nigeria's Clinical Trials Engine | Muhammad Balarabe | ACRN Health Podcast EP12

Send us Fan Mail

In Episode 1 of the PVAC Series we heard why Nigeria built PVAC. Now we get into how it works, starting with clinical trials.

Dr. Wilfred Gurupira talks with Muhammad Balarabe, Ecosystem Enablement Team Lead at PVAC, about why clinical trials matter well beyond labs and pharma. For patients they're a way to access new medicines, and for the economy they bring in investment and create skilled jobs.

In this episode:

• Why the public should care about clinical trials
• What PVAC's national landscape assessment of trial sites found, including sites that once ran major trials but lost that capacity over time
• What makes a site "trial-ready": people, technology, biosafety and systems
• The hub-and-spoke plan to activate 437 trial sites across Nigeria's six geopolitical zones
• The new Nigeria Clinical Research Consortium
• Why training alone isn't enough without lasting capacity
• How locally generated evidence and patents can turn research into export value for a West African market of 400M+ people

"Trials in Nigeria does not mean cheap trials."

Coming up in Episode 3, Financing the Future: From Deals to Delivery, Abuja to Every State, we follow the money.

Subscribe, share and join the conversation on research in Africa.